MATTHEW HEBERT: Open Payments
NPI 1942235486 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$81 in 4 payments from 4 companies in 2025. Trend: 2023 $66 · 2024 $0 · 2025 $81
Food & beverage: $81
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $24 |
| Cipher Pharmaceuticals US LLC | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Cranial Technologies, Inc | 1 | $17 |
Products named: BEXSERO, Natroba, Qelbree, Doc Band.
Industry payments across LA — which companies pay providers there.
